IBDEI1F1 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22899,1,3,0)
 ;;=3^Benign Neop Skin Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,22899,1,4,0)
 ;;=4^D23.111
 ;;^UTILITY(U,$J,358.3,22899,2)
 ;;=^5157290
 ;;^UTILITY(U,$J,358.3,22900,0)
 ;;=L92.0^^76^985^1
 ;;^UTILITY(U,$J,358.3,22900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22900,1,3,0)
 ;;=3^Granuloma Annulare
 ;;^UTILITY(U,$J,358.3,22900,1,4,0)
 ;;=4^L92.0
 ;;^UTILITY(U,$J,358.3,22900,2)
 ;;=^184052
 ;;^UTILITY(U,$J,358.3,22901,0)
 ;;=D18.01^^76^986^1
 ;;^UTILITY(U,$J,358.3,22901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22901,1,3,0)
 ;;=3^Hemangioma of Skin/Subcutaneous Tissue
 ;;^UTILITY(U,$J,358.3,22901,1,4,0)
 ;;=4^D18.01
 ;;^UTILITY(U,$J,358.3,22901,2)
 ;;=^267697
 ;;^UTILITY(U,$J,358.3,22902,0)
 ;;=L68.0^^76^986^2
 ;;^UTILITY(U,$J,358.3,22902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22902,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,22902,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,22902,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,22903,0)
 ;;=L68.9^^76^986^5
 ;;^UTILITY(U,$J,358.3,22903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22903,1,3,0)
 ;;=3^Hypertrichosis,Unspec
 ;;^UTILITY(U,$J,358.3,22903,1,4,0)
 ;;=4^L68.9
 ;;^UTILITY(U,$J,358.3,22903,2)
 ;;=^5009267
 ;;^UTILITY(U,$J,358.3,22904,0)
 ;;=L74.510^^76^986^3
 ;;^UTILITY(U,$J,358.3,22904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22904,1,3,0)
 ;;=3^Hyperhidrosis,Primary,Focal,Axilla
 ;;^UTILITY(U,$J,358.3,22904,1,4,0)
 ;;=4^L74.510
 ;;^UTILITY(U,$J,358.3,22904,2)
 ;;=^5009290
 ;;^UTILITY(U,$J,358.3,22905,0)
 ;;=L81.4^^76^986^4
 ;;^UTILITY(U,$J,358.3,22905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22905,1,3,0)
 ;;=3^Hyperpigmentation,Other
 ;;^UTILITY(U,$J,358.3,22905,1,4,0)
 ;;=4^L81.4
 ;;^UTILITY(U,$J,358.3,22905,2)
 ;;=^5009314
 ;;^UTILITY(U,$J,358.3,22906,0)
 ;;=L91.0^^76^986^6
 ;;^UTILITY(U,$J,358.3,22906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22906,1,3,0)
 ;;=3^Hypertrophic Scar
 ;;^UTILITY(U,$J,358.3,22906,1,4,0)
 ;;=4^L91.0
 ;;^UTILITY(U,$J,358.3,22906,2)
 ;;=^5009459
 ;;^UTILITY(U,$J,358.3,22907,0)
 ;;=L91.8^^76^986^7
 ;;^UTILITY(U,$J,358.3,22907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22907,1,3,0)
 ;;=3^Hypertrophic Skin Disorders
 ;;^UTILITY(U,$J,358.3,22907,1,4,0)
 ;;=4^L91.8
 ;;^UTILITY(U,$J,358.3,22907,2)
 ;;=^5009460
 ;;^UTILITY(U,$J,358.3,22908,0)
 ;;=L90.0^^76^987^14
 ;;^UTILITY(U,$J,358.3,22908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22908,1,3,0)
 ;;=3^Lichen Sclerosus et Atrophicus
 ;;^UTILITY(U,$J,358.3,22908,1,4,0)
 ;;=4^L90.0
 ;;^UTILITY(U,$J,358.3,22908,2)
 ;;=^70699
 ;;^UTILITY(U,$J,358.3,22909,0)
 ;;=L28.0^^76^987^15
 ;;^UTILITY(U,$J,358.3,22909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22909,1,3,0)
 ;;=3^Lichen Simplex Chronicus
 ;;^UTILITY(U,$J,358.3,22909,1,4,0)
 ;;=4^L28.0
 ;;^UTILITY(U,$J,358.3,22909,2)
 ;;=^259859
 ;;^UTILITY(U,$J,358.3,22910,0)
 ;;=L66.1^^76^987^11
 ;;^UTILITY(U,$J,358.3,22910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22910,1,3,0)
 ;;=3^Lichen Planopilaris
 ;;^UTILITY(U,$J,358.3,22910,1,4,0)
 ;;=4^L66.1
 ;;^UTILITY(U,$J,358.3,22910,2)
 ;;=^5009253
 ;;^UTILITY(U,$J,358.3,22911,0)
 ;;=L43.0^^76^987^12
 ;;^UTILITY(U,$J,358.3,22911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22911,1,3,0)
 ;;=3^Lichen Planus,Hypertrophic
 ;;^UTILITY(U,$J,358.3,22911,1,4,0)
 ;;=4^L43.0
 ;;^UTILITY(U,$J,358.3,22911,2)
 ;;=^5009178
